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The data described in this article is the subject of an article in the
American Journal of Physiology: Cell Physiology, titled “The Human
Uterine Smooth Muscle S-nitrosoproteome Fingerprint in Preg-
nancy, Labor, and Preterm Labor” (http://dx.doi.org/10.1152/ajpcell.
00198.2013) (Ulrich et al., 2013) [1]. The data described is a large
scale mass spectrometry data set that deﬁnes the human uterine
smooth muscle S-nitrosoproteome differences among laboring,
non-laboring, preterm laboring tissue after treatment with
S-nitrosoglutathione.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations TableSubject area Pharmacology
More speciﬁc subject
areaReproductive Biology, Preterm LaborType of data .XML and. RAW ﬁles
How data was
acquiredMass Spectrometry (Thermo-Fisher LTQ-Orbitrap)vier Inc. This is an open access article under the CC BY license
C.C. Ulrich et al. / Data in Brief 4 (2015) 591–594592Data format Filtered XML ﬁles and RAW ﬁles
Experimental factors Samples were treated with S-nitrosoglutathione and S-nitrosated proteins were isolated by the biotin-
switch technique.
Experimental
featuresLC/MS/MS analysis of enriched S-nitrosated proteins from human uterine smooth muscle in disparate
states of pregnancy.Data source location PRIDE Archive
Data accessibility Freely available in the PRIDE Archive (Project PXD000226) http://www.ebi.ac.uk/pride/archive/projects/
PXD000226Value of the data
This is the ﬁrst and only description of nitric oxide (NO)-mediated post-translational modiﬁcation
in human uterine smooth muscle. This data provides a target list for future work delineating nitric oxide signaling pathways in
human pregnancy. Because relaxation of the uterine smooth muscle is independent of soluble guanylyl cyclase
activation and cGMP accumulation, this data set likely includes the S-nitroso proteins responsible
for NO-mediated relaxation. The raw data can be used by all smooth muscle and reproductive scientists to formulate their own
unique hypotheses regarding the role of nitric oxide in the posttranslational modiﬁcation of
cysteine residues in smooth muscle.
1. Data, experimental design, materials and methods
1.1. Data
The data in the PRIDE Archive provide a novel description of the NO-induced posttranslational
modiﬁcations that were identiﬁed in human uterine smooth muscle during disparate states of
pregnancy. This data can be analyzed using a variety of free and commercial tandemmass spectrometry
tools currently available, such as MaxQuant and the Trans-Proteomic Pipeline. We have provided a
descriptive MS/MS data set of peptides identiﬁed in human uterine smooth muscle that show disparate
reactivity to S-nitrosoglutathione in different pregnancy states. The following materials and methods, as
well as data parsing sections, will enable investigators to design novel procedures involved in NO
signaling that rely on MS/MS techniques.2. Materials and methods
2.1. Chemicals
Sodium ascorbate, N-2-hydroxyethylpiperazine-N0-2-ethanesulfonic acid (HEPES), neocuproine,N-
ethylmaleimide (NEM), methyl methanethiosulfonate (MMTS), 3-(3-cholamidopropyl)dimethylammo-
nio-1-propanesulfonate (CHAPS), sodium dodecyl sulfate (SDS), and all other chemicals unless speciﬁed
were obtained from Sigma (St. Louis, MO). N-[6-(biotinamido)hexyl]-30-(20-pyridyldithio) propionamide
(biotin-HPDP) was purchased from Thermo Scientiﬁc (Rockford, IL).
2.2. Tissue collection
All research works were reviewed and approved by the University of Nevada Biomedical Review
Committee for the protection of human subjects. Human uterine myometrial biopsies were obtained with
C.C. Ulrich et al. / Data in Brief 4 (2015) 591–594 593written informed consent from mothers undergoing elective Cesarean section in preterm labor without
infection or premature rupture of membranes; term in labor or term not in labor. Tissues were transported
to the laboratory immediately in cold physiological buffer, microdissected under magniﬁcation to isolate
smooth muscle, employed in contractile experiments or snap frozen in liquid nitrogen, and stored at
80 1C. The average age for patients in the pregnant laboring group was 28.975.6 yr in the nonlaboring
group 2875.1 yr and in the preterm laboring group 30.8710.2 yr. Pregnant laboring and nonlaboring
patients ranged from 37 to 41 wk gestation, with the mean at 39 wk for both laboring and nonlaboring
groups. Preterm laboring patients ranged from 29.2 to 36 wk of gestation, with the mean being 33.5 wk.
Patients represented a range of ethnicities and were 52% Caucasian, 30% Hispanic, 7.4% African American,
and 11% other.
2.3. Protein isolation
To isolate total protein, myometrial muscle samples from 12 patients in each pregnancy state were
ground to a powder under liquid nitrogen and reconstituted in 20ml HEN buffer (25mM HEPES-NaOH,
1 mMEDTA, and 0.1 mMneocuproine, pH 7.7). Samples were sonicated (102- s bursts, 70% duty cycle) and
brought to 0.4% CHAPS. Samples were then centrifuged at 2000g for 10 min at 4 1C. Protein concentration
was determined by the bicinchoninic acid assay and samples diluted to 0.8 mg/ml in HEN buffer.
2.4. Biotin switch and streptavidin pull-down
Samples from each patient in all groups were independently isolated by biotin switch and
streptavidin pulldown and then pooled for tandem mass spectrometry (MS/MS) analysis (i.e., PTL1,
4 unique patients; PTL2, 4 unique patients; PTL3, 4 unique patients; for a total of 12 unique patients split
into 3 biological replicates to help control for human diversity). Unless stated, all steps of the biotin
switch were performed in the dark. Protein isolates (1.8 ml 0.8 mg/ml in HEN buffer) were incubated
with GSNO (1746 μl of sampleþ54 μl of 10 mM GSNO prepared in the dark) for 20 min at room
temperature. We selected a concentration for this labeling of 300 μM because at this concentration,
GSNO will produce 5 μM reactive NO over 15–20 min without accumulation [2]. This reactive species
concentration matches the IC50 concentration for relaxation of isolated myometrium [3]. Noncysteinyl
nitrosation events would not be appreciated due to the reactive chemistry of ascorbate reduction; a
nucleophilic attack at the nitroso-nitrogen atom leading to thiol and O-nitrosoascorbate (reaction 1)
RSNOþASC-RSHþNOASC
which breaks down, by various competitive pathways, the dominant of which at physiological pH
yields dehydroascorbic acid and nitroxyl radical that decomposes at physiological pH to nitrous oxide
[4] (reaction 2).
NOASCþHþ-DHAþHNO
2HNO-HON¼NOH
HON¼NOH-N2OþH2O
Neither biotin-HPDP nor a maleimide dye would lead to false positives because the amines or tyrosines
would not be labeled even if they were nitrosated. SDS (0.2 ml of 25% SDS in water) was added along with
20 μl of 3 MNEM (ﬁnal 2.0 ml at 2.5% SDS and 30mMNEM). Samples were incubated at 50 1C in the dark for
20 min with frequent vortexing. Three volumes of cold acetone (6 ml) were added to each sample. Proteins
were precipitated for 1 h at 20 1C and collected by centrifugation at 3000g for 10min. The clear
supernatant was aspirated, and the protein pellet was gently washed with 70% acetone (45ml). After
resuspension in 0.24 ml HEN buffer with 1% SDS (HENS), the material was transferred to a fresh 1.7- ml
microfuge tube containing 30 μl biotin-HPDP (2.5 mg/ml). The labeling reaction was initiated by addition
30 μl of 200mM sodium ascorbate (ﬁnal 20mM ascorbate) for 1 h at room temperature in the dark. Four
volumes of 20 1C acetone were added to the labeled samples and incubated at 20 1C for 20min to
remove biotin-HPDP. The samples were centrifuged at 3000g for 10min at 4 1C, and the supernatant was
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HPDP. The pellet was resuspended in 140 μl of HENS buffer. Neutralization buffer (20mM HEPES pH 7.7,
100mM NaCl, 1 mM EDTA, and 0.5% Triton X-100) was added (280 μl) along with 42 μl of streptavidin-
agarose. Proteins were incubated for 1 h at room temperature and washed ﬁve times with 1.5 ml of
neutralization buffer with 600mM NaCl. Beads were incubated with 100 μl elution buffer (neutralization
buffer with 600mMNaCl plus 100mM β-mercaptoethanol) to recover the bound proteins. This step releases
the protein from the streptavidin bead leaving the biotin-HPDP tag bound to the bead as well as natively
biotinylated proteins still bound to the bead. Four volumes of 20 1C acetonewere added, and samples were
incubated for 1 h at 20 1C to reprecipitate proteins. Samples were centrifuged at 3000g for 10 min at 4 1C,
the supernatant was discarded, and the pellet was washed and dried for proteomic analysis.
2.5. Protein digestion and mass spectrometry
The Nevada Proteomics Center analyzed selected proteins by trypsin digestion and liquid chromotography
(LC)/MS/MS analysis. Acetone-precipitated pellets were washed twice with 25mM ammonium bicarbonate
and 100% acetonitrile, reduced, and alkylated using 10mM dithiothreitol and 100mM iodoacetamide and
incubated with 75 ng sequencing grade-modiﬁed porcine trypsin (Promega, Fitchburg WI) in 25mM
ammonium bicarbonate overnight at 37 1C. Peptides were ﬁrst separated by Michrom Paradigm Multi-
Dimensional Liquid Chromatography (MDLC) instrument [Magic C18AQ 3μ 200 Å (0.250mm) column
(Michrom Bioresources, Auburn, CA) with an Agilent ZORBAX 300SB-C18 5μ (50.3 mm) trap (Agilent
Technologies, Santa Clara, CA)]. The gradient employed 0.1% formic acid in water (pump A) and 0.1% formic
acid in acetonitrile (pump B) as follows time (min), ﬂow (μl/min), pump B (%): (0.00, 4.00, 5.00), (5.00, 4.00,
5.00), (95.00, 4.00, 45.00), (95.10, 4.00, 80.00), (96.10, 4.00, 80.00), (96.20, 4.00, 5.00). Eluted peptides were
analyzed using a Thermo Finnigan LTQ-Orbitrap using Xcalibur v 2.0.7. MS spectra (m/z 300–2000) were
acquired in the positive ion mode with resolution of 60,000 in proﬁle mode. The top 4 data-dependent
signals were analyzed by MS/MS with CID activation, minimum signal of 50,000, isolation width of 3.0, and
normalized collision energy of 35.0. The reject mass list included the following: 323.2040, 356.0690, 371.1010,
372.1000, 373.0980, 445.1200, 523.2840, 536.1650, 571.5509, 572.5680, 575.5494, 677.6090, 737.7063,
747.3510, 761.7316, 763.8791, 767.0623, 824.4870, 832.1884, 930.1760, 1106.0552, 1106.0564, 1142.0940, and
1150.0927. Dynamic exclusion settings were used with a repeat count of two, repeat duration of 10 s,
exclusion list size of 500, and exclusion duration of 30 s.
2.6. Data processing and upload to the PRIDE repository
All raw data acquired on the LTQ-Orbitrap is available in the PRIDE Repository in the Thermo
Fisher.RAW format. All.RAW,.MS2, and.MGF data was translated into the PRIDE XML format and is
freely available in the PRIDE repository at the following web address: http://www.ebi.ac.uk/pride/
archive/projects/PXD000226.
References
[1] C. Ulrich, D.R. Quilici, K.A. Schlauch, I.L. Buxton, The human uterine smooth muscle S-nitrosoproteome ﬁngerprint in pregnancy,
labor, and preterm labor, Am. J. Physiol. Cell Physiol. 305 (2013) C803–C816, http://dx.doi.org/10.1152/ajpcell.00198.2013.
[2] M.W. Cleeter, J.M. Cooper, V.M. Darley-Usmar, S. Moncada, A.H. Schapira, Reversible inhibition of cytochrome c oxidase, the
terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases, FEBS
Lett. 345 (1994) 50–54.
[3] I.L. Buxton, R.A. Kaiser, N.A. Malmquist, S. Tichenor, NO-induced relaxation of labouring and non-labouring human
myometrium is not mediated by cyclic GMP, Br, J. Pharamcol. 134 (2001) 206–214.
[4] M. Kirsch, A.M. Buscher, S. Aker, R. Schulz, H. de Groot, New insights into the S-nitrosothiol-ascorbate reaction. The
formation of nitroxyl, Org. Biomol. Chem. 7 (2009) 1954–1962, http://dx.doi.org/10.1039/b901046g.
